Comparison of 18-F Sodium Fluoride Uptake in Culprit Plaques Between Acute Coronary Syndrome and Stable Angina
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01665248
: August 15, 2012
Last Update Posted
: July 28, 2014
CHEOL WHAN LEE, MD, PhD.
Information provided by (Responsible Party):
CHEOL WHAN LEE, MD, PhD., CardioVascular Research Foundation, Korea
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
21 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Age more than 20
Acute coronary syndrome or stable angina
Contraindications to the use of heparin, aspirin, clopidogrel, stainless metal, contrast media
Acute ST segment elevation myocardial infarction within 12hours, heart failure, cardiac shock
Any serious medical comorbidity such that the subject's life expectancy is less than 24 months
Ejection fraction less than 30
Serum creatinine level of 1.5mg/dl and over
Unwillingness or inability to cooperate or to give informed consent